D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 102.4 SEK 1.19%
Market Cap: 1.7B SEK

Wall Street
Price Targets

DVYSR Price Targets Summary
Devyser Diagnostics AB

Wall Street analysts forecast DVYSR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVYSR is 166.26 SEK with a low forecast of 136.35 SEK and a high forecast of 201.6 SEK.

Lowest
Price Target
136.35 SEK
33% Upside
Average
Price Target
166.26 SEK
62% Upside
Highest
Price Target
201.6 SEK
97% Upside
Devyser Diagnostics AB Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
237% Upside
ONCO
Oncopeptides AB
171% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
58% Upside
ARGX
argenx SE
37% Upside
IMAB
I-Mab
325% Upside
2616
CStone Pharmaceuticals
28% Downside
XGN
Exagen Inc
3% Upside
LTRN
Lantern Pharma Inc.
657% Upside

Revenue
Forecast

Revenue Estimate
Devyser Diagnostics AB

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 3 years is 34%.

28%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat

Net Income
Forecast

Net Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVYSR's stock price target?
Price Target
166.26 SEK

According to Wall Street analysts, the average 1-year price target for DVYSR is 166.26 SEK with a low forecast of 136.35 SEK and a high forecast of 201.6 SEK.

What is Devyser Diagnostics AB's Revenue forecast?
Projected CAGR
34%

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 3 years is 34%.

Back to Top